Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial

por Ahi, Mohammadreza, Hamidi Farahani, Ramin, Basiri, Pouria, Karimi Rahjerdi, Ahmad, Sheidaei, Ali, Gohari, Kimiya, Rahimi, Zahra, Gholami, Fatemeh, Moradi, Milad, Ghafoori Naeeni, Farzad, Saffar, Kosar Naderi, Ghasemi, Soheil, Barati, Babak, Moradi, Sohrab, Monazah, Arina, Pouranvari, Fatemeh, Forooghizadeh, Mohsen
Publicado 2022

Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial

por Solaymani-Dodaran, Masoud, Basiri, Pouria, Moradi, Milad, Gohari, Kimiya, Sheidaei, Ali, Ahi, Mohammadreza, Ghafoori Naeeni, Farzad, Ansarifar, Akram, Rahimi, Zahra, Gholami, Fatemeh, Karimi Rahjerdi, Ahmad, Hamidi Farahani, Ramin, Naderi saffar, Kosar, Ghasemi, Soheil, Shooshtari, Ali, Honari, Mohsen, Mozafari, Ali, Khodaverdloo, Samane, Forooghizadeh, Mohsen
Publicado 2023

Development of Inactivated FAKHRAVAC(®) Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models

por Ghasemi, Soheil, Naderi Saffar, Kosar, Ebrahimi, Firooz, Khatami, Pezhman, Monazah, Arina, Alizadeh, Ghorban-Ali, Ettehadi, Hossein-Ali, Rad, Iman, Nojehdehi, Shahrzad, Kehtari, Mousa, Kouhkan, Fatemeh, Barjasteh, Hesam, Moradi, Sohrab, Ghorbani, Mohammad-Hosein, Khodaie, Ali, Papizadeh, Moslem, Najafi, Roghayeh, Naghneh, Ehsan, Sadeghi, Davood, Karimi Rahjerdi, Ahmad
Publicado 2021

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18–55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial...

por Ansarifar, Akram, Farahani, Ramin Hamidi, Rahjerdi, Ahmad Karimi, Ahi, Mohammadreza, Sheidaei, Ali, Gohari, Kimiya, Rahimi, Zahra, Gholami, Fatemeh, Basiri, Pouria, Moradi, Milad, Jahangiri, Arash, Naderi, Kosar, Ghasemi, Soheil, Khatami, Pezhman, Honari, Mohsen, Khodaverdloo, Samane, Shooshtari, Mohammad, Azin, Hajar Mehr, Moradi, Sohrab, Shafaghi, Batool, Allahyari, Hossein, Monazah, Arina, Poor, Ali Khodaei, Bakhshande, Hooman, Taghva, Zahra, Nia, Mohammad Karimi, Dodaran, Masoud Solaymani, Foroughizadeh, Mohsen
Publicado 2023

Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18–70 years

por Gholami, Fatemeh, Hamidi Farahani, Ramin, Karimi Rahjerdi, Ahmad, Ahi, Mohammadreza, Sheidaei, Ali, Gohari, Kimiya, Rahimi, Zahra, Ansarifar, Akram, Basiri, Pouria, Moradi, Milad, Jahangiri, Arash, Naderi, Kosar, Ghasemi, Soheil, Khatami, Pezhman, Honari, Mohsen, Khodaverdloo, Samane, Shooshtari, Mohammad, Mehr Azin, Hajar, Moradi, Sohrab, Shafaghi, Batool, Allahyari, Hossein, Monazah, Arina, Khodaei Poor, Ali, Taghva, Zahra, Bakhshande, Hooman, Karimi Nia, Mohammad, Solaymani Dodaran, Masoud, Forooghizade, Mohsen
Publicado 2023